Birdwatch Note
2024-11-01 04:52:38 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
この話は流出情報ではなく、下記の無茶な誤情報を流す遍歴の方が何の根拠もあげず語った数字です。 https://community-notes-leaderboard.com/users/hasibiro_maga https://x.com/hasibiro_maga/status/1834213578834149598 レプリコン治験で５人が死亡との話は、元々、日本ではなく、ベトナムの治験のプラセボ群にも、コスタイベを投与する前の約３か月間のワクチン群の死亡数ですし(全て接種との因果関係はなし)、同期間に、プラセボ群はほぼ同じ母集団数から16人が死亡しています。 https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_3.pdf#page=29 国内4300人の治験という噂の約880名はMeijiのワクチンの２治験です(下記の噂例参照)。 https://x.com/corowaku_memo/status/1778965846779691040 そして、この２治験は結果が公表済で共に長期追跡し死者は０です。(該当ページはいずれもURL末尾に) https://web.archive.org/web/20240120232711/https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_2.pdf#page=30 https://www.pmda.go.jp/drugs/2024/P20240917001/780009000_30500AMX00282_A100_1.pdf#page=17
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1852182939465060546
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1852212127412687278
- noteId - 1852212127412687278
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1730436758269
- tweetId - 1852182939465060546
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- この話は流出情報ではなく、下記の無茶な誤情報を流す遍歴の方が何の根拠もあげず語った数字です。 https://community-notes-leaderboard.com/users/hasibiro_maga https://x.com/hasibiro_maga/status/1834213578834149598 レプリコン治験で５人が死亡との話は、元々、日本ではなく、ベトナムの治験のプラセボ群にも、コスタイベを投与する前の約３か月間のワクチン群の死亡数ですし(全て接種との因果関係はなし)、同期間に、プラセボ群はほぼ同じ母集団数から16人が死亡しています。 https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_3.pdf#page=29 国内4300人の治験という噂の約880名はMeijiのワクチンの２治験です(下記の噂例参照)。 https://x.com/corowaku_memo/status/1778965846779691040 そして、この２治験は結果が公表済で共に長期追跡し死者は０です。(該当ページはいずれもURL末尾に) https://web.archive.org/web/20240120232711/https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_2.pdf#page=30 https://www.pmda.go.jp/drugs/2024/P20240917001/780009000_30500AMX00282_A100_1.pdf#page=17
Note Ratings
| rated at | rated by | |
| 2024-11-01 09:59:49 -0500 | Rating Details | |
| 2024-11-01 09:28:42 -0500 | Rating Details | |
| 2024-11-01 09:27:44 -0500 | Rating Details | |
| 2024-11-01 08:06:40 -0500 | Rating Details | |
| 2024-11-01 07:09:39 -0500 | Rating Details | |
| 2024-11-01 06:55:27 -0500 | Rating Details | |
| 2024-11-01 05:33:19 -0500 | Rating Details | |
| 2024-11-01 05:03:55 -0500 | Rating Details | |
| 2024-11-01 04:25:07 -0500 | Rating Details | |
| 2024-11-01 04:20:52 -0500 | Rating Details | |
| 2024-11-01 03:05:16 -0500 | Rating Details | |
| 2024-11-01 02:31:57 -0500 | Rating Details | |
| 2024-11-01 01:40:26 -0500 | Rating Details | |
| 2024-11-01 00:43:27 -0500 | Rating Details | |
| 2024-11-01 00:08:12 -0500 | Rating Details | |
| 2024-11-01 00:00:46 -0500 | Rating Details | |
| 2024-11-02 09:11:19 -0500 | Rating Details | |
| 2024-11-01 05:03:50 -0500 | Rating Details | |
| 2024-11-01 03:29:22 -0500 | Rating Details | |
| 2024-11-01 02:03:20 -0500 | Rating Details | |
| 2024-11-01 01:23:00 -0500 | Rating Details | |
| 2024-11-01 01:16:50 -0500 | Rating Details | |
| 2024-11-01 01:01:56 -0500 | Rating Details | |
| 2024-11-01 00:29:17 -0500 | Rating Details | |
| 2024-11-01 00:27:02 -0500 | Rating Details | |
| 2024-11-01 00:19:01 -0500 | Rating Details | |
| 2024-11-05 15:31:51 -0600 | Rating Details | |
| 2024-11-01 17:16:43 -0500 | Rating Details | |
| 2024-11-01 08:38:42 -0500 | Rating Details | |
| 2024-11-01 07:26:34 -0500 | Rating Details | |
| 2024-11-01 05:58:31 -0500 | Rating Details | |
| 2024-11-01 03:40:05 -0500 | Rating Details | |
| 2024-11-01 01:30:03 -0500 | Rating Details | |
| 2024-11-01 00:45:40 -0500 | Rating Details | |
| 2024-11-01 00:23:18 -0500 | Rating Details | |
| 2024-11-01 00:16:14 -0500 | Rating Details | |
| 2024-11-01 00:10:51 -0500 | Rating Details | |
| 2024-11-01 00:03:52 -0500 | Rating Details | |
| 2024-10-31 23:59:41 -0500 | Rating Details | |
| 2024-11-07 08:43:39 -0600 | Rating Details | |
| 2024-11-06 23:08:02 -0600 | Rating Details | |
| 2024-11-05 05:33:57 -0600 | Rating Details | |
| 2024-11-01 05:59:32 -0500 | Rating Details | |
| 2024-11-01 04:08:23 -0500 | Rating Details | |
| 2024-11-01 02:19:22 -0500 | Rating Details | |
| 2024-11-01 01:09:45 -0500 | Rating Details | |
| 2024-11-01 01:06:36 -0500 | Rating Details | |
| 2024-11-01 00:47:23 -0500 | Rating Details | |
| 2024-11-01 00:20:41 -0500 | Rating Details | |
| 2024-11-02 21:45:36 -0500 | Rating Details | |
| 2024-11-02 05:48:41 -0500 | Rating Details | |
| 2024-11-01 08:44:36 -0500 | Rating Details | |
| 2024-11-01 08:32:42 -0500 | Rating Details | |
| 2024-11-01 07:26:53 -0500 | Rating Details | |
| 2024-11-01 02:03:55 -0500 | Rating Details | |
| 2024-11-01 01:58:14 -0500 | Rating Details | |
| 2024-11-01 00:08:55 -0500 | Rating Details | |
| 2024-11-01 00:04:03 -0500 | Rating Details |